X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6615) 6615
Magazine Article (9) 9
Book Chapter (6) 6
Book / eBook (4) 4
Web Resource (4) 4
Conference Proceeding (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
triazines - pharmacology (3834) 3834
science & technology (3750) 3750
life sciences & biomedicine (3603) 3603
animals (3270) 3270
humans (2787) 2787
male (2098) 2098
pharmacology & pharmacy (1602) 1602
rats (1336) 1336
female (1265) 1265
triazines - chemistry (1021) 1021
triazines - therapeutic use (1019) 1019
mice (1001) 1001
lamotrigine (832) 832
dose-response relationship, drug (757) 757
triazines - chemical synthesis (710) 710
adult (695) 695
neurosciences & neurology (667) 667
chemistry (621) 621
structure-activity relationship (583) 583
triazines - administration & dosage (523) 523
triazines - pharmacokinetics (493) 493
physical sciences (488) 488
biochemistry & molecular biology (476) 476
triazines (475) 475
middle aged (468) 468
neurosciences (439) 439
antineoplastic agents - pharmacology (432) 432
anticonvulsants - therapeutic use (431) 431
in vitro techniques (422) 422
triazines - metabolism (421) 421
analysis (411) 411
anticonvulsants - pharmacology (404) 404
triazines - adverse effects (392) 392
molecular structure (375) 375
clinical neurology (367) 367
chemistry, medicinal (360) 360
time factors (358) 358
rats, sprague-dawley (346) 346
toxicology (343) 343
triazoles - pharmacology (324) 324
rats, wistar (319) 319
kinetics (318) 318
epilepsy - drug therapy (313) 313
drug interactions (309) 309
cell line, tumor (307) 307
imidazoles - pharmacology (307) 307
oncology (292) 292
triazines - blood (290) 290
vardenafil dihydrochloride (290) 290
adolescent (277) 277
treatment outcome (277) 277
triazines - toxicity (268) 268
enzyme inhibitors - pharmacology (257) 257
anticonvulsants (256) 256
epilepsy (248) 248
psychiatry (242) 242
piperazines - pharmacology (241) 241
models, molecular (237) 237
cells, cultured (236) 236
aged (229) 229
research (228) 228
triazine (228) 228
research article (223) 223
disease models, animal (222) 222
drug therapy, combination (222) 222
anticonvulsants - adverse effects (221) 221
cell line (219) 219
binding sites (206) 206
child (195) 195
anticonvulsants - pharmacokinetics (192) 192
cell survival - drug effects (192) 192
administration, oral (187) 187
herbicides - pharmacology (180) 180
drug resistance (175) 175
drug design (172) 172
pharmacology (172) 172
adenosine - pharmacology (171) 171
abridged index medicus (169) 169
cell biology (168) 168
microbial sensitivity tests (167) 167
anticonvulsants - administration & dosage (164) 164
cell proliferation - drug effects (164) 164
chemistry, organic (163) 163
pyrimidines - pharmacology (163) 163
chemical phenomena (161) 161
drug synergism (159) 159
chemistry, multidisciplinary (158) 158
sulfones - pharmacology (158) 158
antineoplastic agents - chemical synthesis (155) 155
antineoplastic agents - chemistry (155) 155
protein binding (154) 154
hydrogen-ion concentration (153) 153
bipolar disorder - drug therapy (150) 150
mutation (148) 148
microbiology (147) 147
double-blind method (146) 146
anticonvulsants - blood (144) 144
chromatography, high pressure liquid (143) 143
ligands (143) 143
pharmacokinetics (143) 143
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6291) 6291
German (151) 151
Japanese (130) 130
Russian (83) 83
French (55) 55
Chinese (21) 21
Italian (14) 14
Polish (14) 14
Czech (10) 10
Spanish (7) 7
Ukrainian (7) 7
Portuguese (4) 4
Danish (2) 2
Hungarian (2) 2
Slovak (2) 2
Dutch (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of physiology. Regulatory, integrative and comparative physiology, ISSN 0363-6119, 01/2013, Volume 304, Issue 1, pp. R23 - R32
The interaction between adenosine and soluble epoxide hydrolase (sEH) in vascular response is not known. Therefore, we hypothesized that lack of sEH in mice... 
Relaxation | CYP2J5-epoxgenase;ω-hydroxylase | receptor | Soluble epoxide hydrolase | Contraction | Adenosine A | Epoxide Hydrolases - physiology | Adenosine-5'-(N-ethylcarboxamide) - pharmacology | Butyrates - pharmacology | Male | Receptor, Adenosine A2A - physiology | Lauric Acids - pharmacology | Vasodilation - genetics | 8,11,14-Eicosatrienoic Acid - analogs & derivatives | Adenosine A2 Receptor Agonists - pharmacology | Urea - analogs & derivatives | Female | Benzamides - pharmacology | Oxygenases - physiology | Vasodilation - physiology | 8,11,14-Eicosatrienoic Acid - pharmacology | Adamantane - analogs & derivatives | NG-Nitroarginine Methyl Ester - pharmacology | Adamantane - pharmacology | Triazines - pharmacology | Phenethylamines - pharmacology | Vasodilator Agents - pharmacology | Enzyme Inhibitors - pharmacology | Gene Silencing | Adenosine - pharmacology | Pyrimidines - pharmacology | Epoxide Hydrolases - genetics | Triazoles - pharmacology | Adenosine A2 Receptor Antagonists - pharmacology | PPAR gamma - physiology | Animals | Adenosine - analogs & derivatives | Benzoates - pharmacology | Mice | Phenylurea Compounds - pharmacology | Pyridines - pharmacology | Vasodilation - drug effects | Urea - pharmacology | Index Medicus | adenosine A2a receptor | CYP2J5-epoxgenase | ω-hydroxylase | relaxation | contraction | Cardiovascular and Renal Integration | soluble epoxide hydrolase | adenosine A1 receptor
Journal Article
Journal of sexual medicine, ISSN 1743-6095, 12/2012, Volume 9, Issue 12, pp. 3028 - 3040
Journal Article
Journal Article
Journal Article
The European journal of neuroscience, ISSN 0953-816X, 05/2004, Volume 19, Issue 9, pp. 2464 - 2474
A major subtype of glutamate receptors, AMPA receptors (AMPARs), are generally thought to mediate excitation at mammalian central synapses via the ionotropic... 
presynaptic inhibition | rat | GABAergic inhibitory synapse | AMPA‐type glutamate receptor | cerebellum | Cerebellum | Presynaptic inhibition | AMPA-type glutamate receptor | Rat | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Glycine - analogs & derivatives | Rats, Wistar | Calcium - metabolism | gamma-Aminobutyric Acid - metabolism | Benzoxazines | Neural Inhibition - physiology | Drug Interactions | Piperidines - pharmacology | Egtazic Acid - analogs & derivatives | Neurons - physiology | Neurons - drug effects | Action Potentials - drug effects | Ryanodine - pharmacology | Cyclopropanes - pharmacology | Pyrazoles - pharmacology | Synapses - drug effects | Triazines - pharmacology | Presynaptic Terminals - drug effects | Receptors, AMPA - physiology | Colforsin - pharmacology | Synapses - physiology | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Rats | Excitatory Amino Acid Agonists - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Presynaptic Terminals - physiology | Chelating Agents - pharmacology | Calcium Channel Blockers - pharmacology | Benzothiadiazines - pharmacology | GABA Antagonists - pharmacology | Naphthalenes - pharmacology | Triazoles - pharmacology | Animals | Egtazic Acid - pharmacology | Glycine - pharmacology | Cerebellum - cytology | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacology | In Vitro Techniques | Neural Inhibition - drug effects | Receptors, AMPA - drug effects | Index Medicus
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 11/2004, Volume 110, Issue 19, pp. 3149 - 3155
Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - mortality | Isosorbide Dinitrate - analogs & derivatives | Phosphodiesterase Inhibitors - adverse effects | Cyclic Nucleotide Phosphodiesterases, Type 5 | Humans | Imidazoles - chemistry | Sulfones - adverse effects | Endothelium, Vascular - drug effects | Male | Piperazines - chemistry | Nitroglycerin - pharmacology | Sildenafil Citrate | Purines | Carbolines - chemistry | Drug Interactions | Imidazoles - therapeutic use | Triazines - pharmacology | Imidazoles - adverse effects | Imidazoles - pharmacology | Piperazines - therapeutic use | Arteriosclerosis - complications | Piperazines - adverse effects | Piperazines - pharmacology | Tadalafil | Cyclic GMP - metabolism | Vardenafil Dihydrochloride | Triazines - adverse effects | Vasodilation - drug effects | Myocardial Infarction - chemically induced | Phosphodiesterase Inhibitors - therapeutic use | Sulfones - therapeutic use | Triazines - therapeutic use | Vasodilator Agents - therapeutic use | Adrenergic alpha-Antagonists - pharmacology | Sulfones - pharmacology | Contraindications | Heart Rate - drug effects | Erectile Dysfunction - drug therapy | Sulfones - chemistry | Coronary Disease - complications | Triazines - chemistry | Blood Pressure - drug effects | Molecular Structure | Nitric Oxide Donors - pharmacology | Phosphodiesterase Inhibitors - chemistry | Carbolines - therapeutic use | Carbolines - adverse effects | Vasodilator Agents - pharmacology | Phosphodiesterase Inhibitors - pharmacology | Phosphoric Diester Hydrolases - drug effects | Hypotension - chemically induced | Isosorbide Dinitrate - pharmacology | Randomized Controlled Trials as Topic | 3',5'-Cyclic-GMP Phosphodiesterases | Vasodilator Agents - chemistry | Vasodilator Agents - adverse effects | Carbolines - pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 08/2010, Volume 19, Issue 8, pp. 931 - 945
Importance of the field: c-Src and Bcr-Abl are two non-receptor or cytoplasmic tyrosine kinases (TKs) that play important roles in the development of solid and... 
hematologic malignancies | tyrosine kinases | dual inhibitors | Src | Brc-Abl | solid tumors | Tyrosine kinases | Hematologic malignancies | Solid tumors | Dual inhibitors | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Thiazoles - metabolism | Nitriles - pharmacology | Triazines - therapeutic use | src-Family Kinases | Aniline Compounds - metabolism | Protein-Tyrosine Kinases - metabolism | Humans | Benzodioxoles - metabolism | Antineoplastic Agents - therapeutic use | Thiazoles - therapeutic use | Pyrimidines - metabolism | Quinolines - pharmacology | Quinazolines - metabolism | Antineoplastic Agents - pharmacology | Benzodioxoles - therapeutic use | Drug Evaluation, Preclinical | Dasatinib | Nitriles - metabolism | Triazines - metabolism | Triazines - pharmacology | Aniline Compounds - pharmacology | Rats | Clinical Trials as Topic | Pyrimidines - pharmacology | Mice, SCID | Mice, Knockout | Neoplasms - drug therapy | Quinolines - metabolism | Animals | Mice, Nude | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Dogs | Fusion Proteins, bcr-abl - antagonists & inhibitors | Hematologic Neoplasms - drug therapy | Mice | Protein Kinase Inhibitors - pharmacology | Quinolines - therapeutic use | Thiazoles - pharmacology | Aniline Compounds - therapeutic use | Quinazolines - pharmacology | Benzodioxoles - pharmacology | Fusion Proteins, bcr-abl - metabolism | Nitriles - therapeutic use | Protein Kinase Inhibitors - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article